During the COVID-19 pandemic, adenoviral vaccines drew attention due to a potential life-threatening coagulation disorder, the vaccine-induced immune thrombotic thrombocytopenia (VITT). Patients deceased of VITT have been accepted as organ donors despite safety concerns regarding the transmission of VITT to recipients. The outcome of adult kidney graft recipients was reported favorable in most cases, however, (thrombotic) complications were observed more frequently. We present two pediatric recipients of kidney grafts from VITT-deceased patients.